Table 4.
Time to recovery in active-control trial of sugammadex for the rapid reversal of rocuronium-induced neuromuscular block.5,12,13 *Sugammadex was administered 3 min after rocuronium; **P<0.0001 (study authors’ analysis)
| Rocuronium+sugammadex (16 mg kg−1) (n=55)* | Succinylcholine (1 mg kg−1) (n=55) | |
|---|---|---|
| Time from start of NMBA administration to T1/T0=0.1** | ||
| Mean (sd) | 4.4 (0.7) | 7.1 (1.6) |
| Median (range) | 4.2 (3.5–7.7) | 7.1 (3.7–10.5) |
| Time from start of NMBA administration to T1/T0=0.9** | ||
| Mean (sd) | 6.2 (1.83) | 10.9 (2.42) |
| Median (range) | 5.7 (4.2–13.6) | 10.7 (5.0–16.2) |
| Time from start of sugammadex administration to T4/T1=0.9 | ||
| Mean (sd) | 2.2 (2.2) | |
| Median (range) | 1.73 (0.48–14.3) | |